Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1955 2
1959 1
1960 4
1961 8
1962 11
1963 14
1964 14
1965 6
1966 13
1967 18
1968 10
1969 8
1970 14
1971 15
1972 11
1973 8
1974 12
1975 13
1976 9
1977 20
1978 21
1979 18
1980 21
1981 17
1982 32
1983 28
1984 40
1985 28
1986 35
1987 24
1988 46
1989 43
1990 43
1991 41
1992 48
1993 41
1994 50
1995 45
1996 59
1997 65
1998 84
1999 96
2000 77
2001 72
2002 87
2003 82
2004 93
2005 121
2006 120
2007 111
2008 98
2009 139
2010 127
2011 135
2012 172
2013 171
2014 194
2015 213
2016 228
2017 201
2018 184
2019 182
2020 242
2021 224
2022 181
2023 180
2024 73

Text availability

Article attribute

Article type

Publication date

Search Results

4,436 results

Results by year

Filters applied: . Clear all
Page 1
iPLAT1: the first-in-human clinical trial of iPSC-derived platelets as a phase 1 autologous transfusion study.
Sugimoto N, Kanda J, Nakamura S, Kitano T, Hishizawa M, Kondo T, Shimizu S, Shigemasa A, Hirai H, Arai Y, Minami M, Tada H, Momose D, Koh KR, Nogawa M, Watanabe N, Okamoto S, Handa M, Sawaguchi A, Matsuyama N, Tanaka M, Hayashi T, Fuchizaki A, Tani Y, Takaori-Kondo A, Eto K. Sugimoto N, et al. Among authors: shimizu s. Blood. 2022 Dec 1;140(22):2398-2402. doi: 10.1182/blood.2022017296. Blood. 2022. PMID: 36112961 Free article. Clinical Trial. No abstract available.
Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer.
Umemoto K, Sunakawa Y, Ueno M, Furukawa M, Mizuno N, Sudo K, Kawamoto Y, Kajiwara T, Ohtsubo K, Okano N, Matsuhashi N, Itoh S, Matsumoto T, Shimizu S, Otsuru T, Hasegawa H, Okuyama H, Ohama H, Moriwaki T, Ohta T, Odegaard JI, Nakamura Y, Bando H, Yoshino T, Ikeda M, Morizane C. Umemoto K, et al. Among authors: shimizu s. Br J Cancer. 2023 Apr;128(8):1603-1608. doi: 10.1038/s41416-023-02189-y. Epub 2023 Feb 13. Br J Cancer. 2023. PMID: 36782009 Free PMC article.
The First Synthesis of Subporphyrins.
Shimizu S. Shimizu S. Angew Chem Int Ed Engl. 2023 Mar 1;62(10):e202217099. doi: 10.1002/anie.202217099. Epub 2023 Jan 12. Angew Chem Int Ed Engl. 2023. PMID: 36539354 Review.
Molecular mechanisms and biological roles of GOMED.
Noguchi S, Shimizu S. Noguchi S, et al. Among authors: shimizu s. FEBS J. 2022 Nov;289(22):7213-7220. doi: 10.1111/febs.16281. Epub 2021 Nov 29. FEBS J. 2022. PMID: 34787961 Free article. Review.
Cooperativity in Sorption Isotherms.
Shimizu S, Matubayasi N. Shimizu S, et al. Langmuir. 2023 Oct 3;39(39):13820-13829. doi: 10.1021/acs.langmuir.3c01243. Epub 2023 Sep 22. Langmuir. 2023. PMID: 37738037 Free PMC article.
Aberrant MUC Immunohistochemical Expressions in Inflammatory Bowel Diseases.
Hamamoto Y, Kawamura M, Uchida H, Takagahara K, Katori C, Asai H, Harada H, Shimizu S, Morii E, Yoshida K. Hamamoto Y, et al. Among authors: shimizu s. Appl Immunohistochem Mol Morphol. 2023 Feb 1;31(2):107-112. doi: 10.1097/PAI.0000000000001096. Epub 2022 Dec 28. Appl Immunohistochem Mol Morphol. 2023. PMID: 36728756 Review.
Intestinal Atp8b1 dysfunction causes hepatic choline deficiency and steatohepatitis.
Tamura R, Sabu Y, Mizuno T, Mizuno S, Nakano S, Suzuki M, Abukawa D, Kaji S, Azuma Y, Inui A, Okamoto T, Shimizu S, Fukuda A, Sakamoto S, Kasahara M, Takahashi S, Kusuhara H, Zen Y, Ando T, Hayashi H. Tamura R, et al. Among authors: shimizu s. Nat Commun. 2023 Nov 21;14(1):6763. doi: 10.1038/s41467-023-42424-x. Nat Commun. 2023. PMID: 37990006 Free PMC article.
Nucleome programming is required for the foundation of totipotency in mammalian germline development.
Nagano M, Hu B, Yokobayashi S, Yamamura A, Umemura F, Coradin M, Ohta H, Yabuta Y, Ishikura Y, Okamoto I, Ikeda H, Kawahira N, Nosaka Y, Shimizu S, Kojima Y, Mizuta K, Kasahara T, Imoto Y, Meehan K, Stocsits R, Wutz G, Hiraoka Y, Murakawa Y, Yamamoto T, Tachibana K, Peters JM, Mirny LA, Garcia BA, Majewski J, Saitou M. Nagano M, et al. Among authors: shimizu s. EMBO J. 2022 Jul 4;41(13):e110600. doi: 10.15252/embj.2022110600. Epub 2022 Jun 15. EMBO J. 2022. PMID: 35703121 Free PMC article.
4,436 results